Skip to main content

Table 1 Vaccination and care pathway

From: Non-traumatic coma in young children in Benin: are viral and bacterial infections gaining ground on cerebral malaria?

 

Survived

(n = 59a)

Died

(n = 25a)

P-value

Vaccination

   

BCG

57/58 (98.3)

24/24 (100)

1.00

OPV

56/58 (96.6)

23/24 (95.8)

1.00

DTP-HepB-Hib

51/57 (89.5)

23/24 (95.8)

0.67

PCV13

50/57 (87.7)

20/24 (83.3)

0.72

MMR

48/57 (84.2)

15/24 (62.5)

0.10

YF

44/57 (77.2)

13/24 (54.2)

0.06

Healthcare before hospital admissionb

Heath center

51 (87.9)

23 (92.0)

0.72

Biomedicine consultation

54 (91.5)

22 (88.0)

0.69

Traditional healer consultation

23 (39.0)

11 (44.0)

0.67

Hospitalization

23 (39.0)

6/24 (25.0)

0.23

Treatments before hospital admissionb

Antibiotics

18 (30.5)

2 (8.0)

0.03

Anti-malarial drugs

22 (37.2)

8 (32.0)

0.64

Anti-epileptic drugs

4 (6.8)

0 (0.0)

0.31

Blood transfusions

2 (3.4)

0 (0.0)

1.00

Means of transport

Car

9 (15.3)

4 (16.0)

1.00

Motorcycle

50 (84.8)

21 (84.0)

1.00

Travel time, hours, mean (SD)

1.05 (0.71)

1.10 (0.57)

0.39

Duration of symptoms before admission, days, mean (SD)

4.68 (2.24)

4.72 (2.46)

0.85

  1. Data are numbers (%) of children, unless otherwise indicated
  2. SD standard deviation, BCG Bacille Calmette-Guérin (tuberculosis) vaccine, OPV oral polio vaccine, DTP diphtheria, tetanus, and pertussis vaccine, HepB Hepatitis B vaccine, Hib Hemophilus influenzae type b vaccine, PCV13 Pneumococcal conjugate vaccine (13-valent), MMR measles, mumps, and rubella vaccine, YF yellow fever vaccine
  3. aFor variables for which the number of children examined is less than the total number listed for the group, the numbers for that variable and group examined are noted in the table
  4. bBetween disease onset and admission